Medical charity Medecins Sans Frontieres (MSF) has once again urged Johnson & Johnson (J&J) to not enforce any 'secondary' patents for its ...

“The deal remains just a stop-gap because bedaquiline will only be available to a limited number of countries that will be included in this...

Stop TB Partnership has invited tenders for the production of bedaquiline, the first new therapy to be made available for tuberculosis (TB)...

The latest secondary patent application, if granted, allows J&J to extend the monopoly on the drug used for treatment of drug resistant (DR...

At present, only 2% of over 1.47 lakh patients suffering from multi drug resistant TB in India are currently getting Bedaquiline.

To ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price...

Life-saving drug bedaquiline by US pharma company Johnson & Johnson (J&J) is now being offered at $400 per patient —over 50% cheaper than t...

J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.

J&J has offered to provide one course of the drug bedaquiline for free if the government buys four courses at $900 (₹58,400) each.

India's dependency on charity from global drug makers is making it hard for patients to access new antibiotic drugs such as bedaquiline and...

Union Health Minister J P Nadda, in a written reply, said that the states are being prepared to monitor the treatment of patients with Beda...

In December 2016, the father of an 18-year-old patient suffering from XDR TB took National Institute of Tuberculosis and Respiratory Diseas...

Bedaquiline and Delamanid are considered the drug for patients like the Bihar girl. Both drugs can’t be bought in pharmacies and are availa...

LRS was responding to an affidavit asking whether the govt could provide the bedaquiline directly to the treating doctor instead of the pat...

"Patients need to be constantly monitored, which is why these centres are currently administering the drug only to residents of these six s...

Ahead of World Tuberculosis Day on March 24, government today launched Bedaquiline, a new class of anti-tuberculosis medicine discovered to...

Government officials say there are several reasons for this: bedaquiline is technically still in a trial phase and its cost in some high-in...